It has become evident that the predisposing gene affects the risk of development of advanced adenomas and cancer incidence, the first being the highest for MSH2 carriers [11], and the latter for MLH1 and MSH2 carriers [3, 12]. This evidence concerns the gene MSH2 and adenoma.